Drug Regulation Drug Approval Vaccine Approval Process Vaccine Approval Leadership Drug Approval Process Vaccine Regulation Regulatory Actions Drug Safety Vaccination Guidelines Regulations Leadership Changes Advisory Committees CDC Vaccine Authorization Vaccine Oversight Regulatory Affairs Pregnancy Public Health Decisions Commissioners Regulation Medication Guidelines Guidance Documents Emergency Use Authorization Drug Regulations Public Health Regulations Medical Device Regulation Vaccine Recommendations Public Health Sunscreen Approval Public Health Guidelines Pharmacovigilance Vaccine Guidelines Compassionate Use Program Drug Review Information Management Panel Discussions Gene Therapy Device Regulation Food Regulations
Want to see what podcasts are saying about this topic? Search across 120K+ podcasts. Explore Radar
The agency says the move will target concentrated and lab‑made 7‑hydroxymitragynine products because regulators link them to rising poisonings and local overdose deaths.
